検索結果

treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 ant...

Research and Development System | Research & Development | SENJU Pharmaceutica

ideas and thinking beyond conventional frameworks and preconceptions. Our mission is to look toward the future and swiftly deliver innovative drugs that are truly needed by patients suffering from dis...

临床试验信息 | 研究与开发 | 千寿制药株式会社

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...

临床试验信息 | 研究与开发 | 千寿制药株式会社

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical tr...